LEXINGTON, Mass.--([ BUSINESS WIRE ])--AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that company management will participate at the 24th Annual ROTH Conference on March 13 at 4:30 pm PT in Dana Point, CA. Company management will provide an overview of the company followed by a question and answer period with investors.
A live webcast of the presentation will be accessible through the Investors section of the Companyas website at [ www.amagpharma.com ]. Following the conference, the webcast will be archived on the AMAG Pharmaceuticals, Inc. website until April 13, 2012.
About AMAG Pharmaceuticals, Inc.
AMAG Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia. For additional company information, please visit [ www.amagpharma.com ].